国际皮肤性病学杂志    2006 32 (1): 35-37   ISSN: 2096-5540  CN: 32-1880/R   白塞综合征发病的分子机制研究进展 左付国, 金春林, 李铁男 沈阳市第七人民医院皮肤科, 110003 收稿日期 2005-07-20  修回日期 null  网络版发布日期 null 参考文献  [1] Cohen R,Metzger S,Nahir M,et al.Association of the MIC-A gene and HLA-B51 with Behcet's disease in Arabs and non-Ashkenazi Jews in Israel.Ann Rheum Dis,2002,61:157-160. [2] Mizuki N,Ota M,Katsuyama Y,et al.Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and-B*5108 with Behcet's disease in Greek patients.Tissue Antigens,2002,59:118-121. [3] Paul M,Klein T,Krause I,et al.Allelic distribution of HLA-B*5 in HLA-BS-positive Israeli patients with Behcet's disease.Tissue Antigens,2001,58:185-186. [4] Kotter I,Gunaydin I,Stubiger N,et al.Comparative analysis of the association of HLA-B*51 suballeles with Behcet's disease in patients of German and Turkish origin.Tissue Antigens,2001,58:166-170. [5] Mizuki N,Ota M,Katsuyama Y,et al.HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behcet's disease.Tissue Antigens,2001,58:181-184. [6] Park SH,Park KS,Seo YI,et al.Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease.J Korean Med Sci,2002,17:366-370. [7] Kaya TI,Dur H,Tursen U,et al.Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behcet's disease.Clin Exp Dermatol,2002,27:498-501. [8] Gul A,Hajeer AH,Worthington J,et al.Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23.Arthritis Rheum,2001,44:2693-2696. [9] Touitou I,Magne X,Molinari N,et al.MEFV mutations in Behcet's disease.Hum Mutat,2000,16:271-272. [10] Polat G,Eskandari G,Kaya TI,et al.Association of the platelet glycoprotein Ia C807T/G873A gene polymorphism and thrombosis in Behcet patients.Haematologia (Budap),2002,32:121-128. [11] Kim JU,Chang HK,Lee SS,et al.Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis.Ann Rheum Dis,2003,62:1083-1087. [12] Kim EH,Mok JW,Bang DS,et al.Intercellular adhesion molecule1 polymorphisms in Korean patients with Behcet s disease.J Korean Med Sci,2003,18:415-418. [13] Cho ML,Kim JY,Ko HJ,et al.The MCP-1 promoter-2518 polymorphism in Behcet's disease:correlation between allele types,MCP-1 production and clinical symptoms among Korean patients.Autoimmunity,2004,37:77-80. [14] Tasci B,Direskeneli H,Serdaroglu P,et al.Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behcet patients.Clin Exp Immunol,1998,113:100-104. [15] Hamzaoui K,Hamzaoui A,Guemira F,et al.Cytokine profile in Behcet's disease patients.Relationship with disease activity.Scand J Rheumatol,2002,31:205-210. [16] Li B,Yang P,Zhou H,et al.T-bet expression is upregulated in active Behcet's disease.Br J Ophthalmol,2003,87:1264-1267. [17] Triolo G,Accardo-Palumbo A,Dieli F,et al.Humoral and cell mediated immune response to cow's milk proteins in Behcet's disease.Ann Rheum Dis,2002,61:459-462. [18] Ertenli I,Kiraz S,Celik IC,et al.Changes in the concentration and distribution of tissue factor pathway inhibitor in Behcet's disease and systemic lupus erythematosus:effect on the prethrombotic state.Ann Rheum Dis,2001,60:1149-1151. [19] Cekmen M,Evereklioglu C,Er H,et al.Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behcet's syndrome.Int J Dermatol,2003,42:870-875. [20] Saglam K,Yilmaz MI,Saglam A,et al.Levels of circulating intercellular adhesion molecule-1 in patients with Behcet's disease.Rheumatol Iht,2002,21:146-148. [21] Evereklioglu C,Turkoz Y,Er H,et al.Increased nitric oxide production in patients with Behcet's disease:is it a new activity marker? J Am Acad Dermatol,2002,46:50-54. [22] Karakuzu A,Aktas A,Akcay F.Serum E-selectin and beta 2-microglobulin levels in Behcet's disease.J Int Med Res,2002,30:85-88. [23] Yang P,Chen L,Zhou H,et al.Resistance of lymphocytes to Fasmediated apoptosis in Behcet's disease and Vogt-Koyangi-Harada syndrome.Ocul Immunol Inflamm,2002,10:47-52. [24] Wakisaka S,Takeba Y,Mihara S,et al.Aberrant Fas ligand expression in lymphocytes in patients with Behcet's disease.Int Arch Allergy Immunol,2002,129:175-180. [25] Senturk N,Yildiz L,Sullu Y,et al.Expression of bcl-2 protein in active skin lesions of Behcet's disease.Int J Dermatol,2001,40:747-750. [26] Sullu Y,Senturk N,Yildiz L,et al.Bcl-2 expression in skin pathergy reaction of Behcet's disease.Dermatology,2001,202:90-93. 通讯作者: